CYC116 (CYC-116)

Catalog No. A10248

CYC116 (CYC-116)是一种有效的Aurora A/B抑制剂,Ki为8.0 nM/9.2 nM,对VEGFR2(Ki为44 nM)作用稍弱。
Catalog Num A10248
M. Wt 368.5
Formula C18H20N6OS
Purity >98%
Storage at -20°C 3 years Powder
CAS No. 693228-63-6
Synonyms CYC-116
SMILES CC1=C(SC(=N1)N)C2=NC(=NC=C2)NC3=CC=C(C=C3)N4CCOCC4
CYC116 (CYC-116)是一种有效的Aurora A/B抑制剂,Ki为8.0 nM/9.2 nM,对VEGFR2(Ki为44 nM)作用稍弱。
Targets
Target Value
AuroraAki: 8nM
AuroraBki: 9nM
VEGFR2ki: 44nM
FLT3ki: 44nM
CDK2/CyclinEki: 0.39μM
CDK9/CyclinTki: 0.48μM
p70S6Kki: 0.54μM
Srcki: 0.82μM
CDK4/CyclinDki: 1.09μM
LCKki: 2.8μM
CDK1/CyclinBki: >10μM
CDK7/CyclinHki: >10μM
Ablki: >10μM
Aktki: >10μM
CaMKIIki: >10μM
CK2ki: >10μM
ERK2ki: >10μM
GSK-3αki: >10μM
GSK-3βki: >10μM
PKAki: >10μM
PKCki: >10μM
SAPK2A(p38α)ki: >10μM
PLK1ki: >10μM
In vitro (25°C) DMSO Warmed: 24 mg/mL (65.13 mM)
Water Insoluble
Ethanol Insoluble
In vivo 1% DMSO+30% polyethylene glycol+1% Tween 80 28 mg/mL
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
0.1 mM 27.14 mL 135.69 mL 271.37 mL
0.5 mM 5.43 mL 27.14 mL 54.27 mL
1 mM 2.71 mL 13.57 mL 27.14 mL
5 mM 0.54 mL 2.71 mL 5.43 mL

*The above data is based on the productmolecular weight 368.5. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.